Rare gram-positive infections in cancer patients: Study and literature review

Infectious Diseases in Clinical Practice

Volumn 9, Issue 4, 2000, Pages 141-147

  Shah, Sonal ^c   Vincent, Albert L ^a   Greene, John N ^a,b   Sandin, Ramon L ^b   Gompf, Sandra ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTINEOPLASTIC AGENT; AZLOCILLIN; AZTREONAM; CEFADROXIL; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; METRONIDAZOLE; MEZLOCILLIN; NAFCILLIN; NETILMICIN; PENICILLIN G; PIPERACILLIN; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL INFECTION; CANCER; CANCER CHEMOTHERAPY; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; GEMELLA; HUMAN; LACTOBACILLUS; LEUCONOSTOC; PEDIOCOCCUS; ROTHIA; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0034063803     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200009040-00001     Document Type: Short Survey

References (44)

1. Williams REO, Hirch A, Cowan ST. Aerococcus, a new bacterial genus. J Gen Microbiol 1953;8:475-80.
2. Buu-Hoi A, Le Bouguenec C, Horaud T. Genetic basis of antibiotic resistance in aerococcus viridans. Antimicrob Agents Chemother 1989;33:529-34.
3. Heilesen A. Septicaemia due to Aerococcus urinae. Scand J Infect Dis 1994;26:759-60.
4. Kern W, Vanek E. Aerococcus bacteremia associated with granulocytopenia. Eur J Clin Microbiol 1997;6:670-3.
5. Gemella RA, Buchanan RE, Gibbons NE, editors. Bergey's manual of determinative bacteriology. 8th ed. Baltimore: Williams & Wilkins; 1974. p. 516-7.
6. Fresard A, Michel VP, Rueda X, et al. Gemella haemolysans endocarditis. Clin Infect Dis 1993;16:586-7.
7. Vasishtha S, Isenberg HD, Sood SK. Gemella morbillorum as a cause of septic shock. Clin Infect Dis 1996;22:1084-6.
8. Buu-Hoi A, Sapoetra A, Branger C, et al. Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clinic Microbiol 1982;1:102-6.
9. Riebel WJ. Gemella species. In: Yu VL, Merigan TC Jr, Barriere SL, editors. Antimicrobial therapy and vaccines. Baltimore: Williams & Wilkins; 1999. p. 206-10.
10. Reed C, Efstratious A, Morrison D, et al. Glycopeptide-resistant Gemella haemolysans from blood. Lancet 1993;392:927-8.
11. Bergan T, Bovre K, Hovig B. Resolution of Micrococcus mucilaginosus Migula 1900. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1970;78:85-97.
12. Kaufhold A, Reinert RR, Kern W. Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection 1992;20:213-20.
13. Lemozy J, Maestre P, Huguet F, et al. Source of infection in Stomatococcus mucilaginous septicemia [letter]. Lancet 1990;335:416.
14. McWhinney PHM, Kibbler CC, Gillespie SH, et al. Stomatococcus mucilaginosus: An emerging pathogen in neutropenic patients. Clin Infect Dis 1992;14:641-6.
15. Weers-Pothoff G, Novakova IR, Donnelly JP, et al. Bacteremia caused by Stomatococcus mucilaginous in a granulocytopenic patient with acute lymphocytic leukemia. Neth J Med 1989;35:143-6.
16. Oppenheim BA, Weightman NC, Prendeville J. Fatal Stomatococcus mucilaginous septicemia in a neutropenic patient [letter]. Eur J Clin Microbiol Infect Dis 1989;8:1004-5.
17. Weinblatt ME, Sahdev I, Berman M. Stomatococcus mucilaginous infection in children with leukemia. Pediatr Infect Dis J 1990;9:678-9.
18. Ascher DP, Zbick C, White C, et al. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991;13:1048-52.
19. Mustafa MM, Carlson LR, Krisher K. Stomatococcus mucilaginosus fatal sepsis in a child with leukemia. Pediatr Infect Dis J 1993;12:784-5.
20. Barlow JF, Vogel KA, Dzintars PF. Septicemia with Stomatococcus mucilaginosus. Clin Microbiol Newsl 1986; 8:170.
21. Mitchell PS, Huston BJ, Jones RN, et al. Stomatococcus mucilaginosus bacteremias: typical case presentations, simplified diagnostic criteria, and a literature review. Diagn Microbiol Infect Dis 1990;13:521-5.
22. Wilcox MH, Spencer RC. Stomatococcus mucilaginosus infection [letter]. Lancet 1991;338:884.
23. Gruson D, Hilbert G, Pigneux A, et al. Severe infection caused by Stomatococcus Mucilaginosus in a neutropenic patient: case report and review of the literature. Hematol Cell Ther 1998;40:167-9.
24. Pinsky RL, Piscitelli V, Patterson JE. Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus. J Clin Microbiol 1989;26:215-6.
25. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995; 39:268-70.
26. Greene JN. Catheter-related complications of cancer therapy. Infect Dis Clin North Am 1996;10:255-95.
27. Husni RN, Gordon SM, Washington JA, et al. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997;25:1048-55.
28. Cooper CD, Vincent A, Greene JN, et al. Lactobacillus bacteremia in febrile neutropenic patients in a cancer hospital. Clin Infect Dis 1998;26:1247-8.
29. Andriessen MPHM, Mulder JG, Sleufer DTH. Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma. Gynecol Oncol 1991;40:87-9.
30. Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 1996;23:773-8.
31. Sharpe ME, Hill LR, Lapage SP. Pathogenic lactobacilli. J Med Microbiol 1973;6:281-6.
32. Chomarat M, Espinouse D. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin [letter]. European J Clin Microbiol Infect Dis 1991;10:44.
33. Bayer AS, Chow AW, Betts D, et al. Lactobacillemia: report of nine cases. Am J Med 1978;64:808-13.
34. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis 1996;22:564-6.
35. Park IS, Walsh CT. D-Alanyl-D-Lactate and D-Alanyl-D-Alanine synthesis by D-Alanyl-D-Alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation. J Biol Chem 1997;272:9210-14.
36. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990;34:543-9.
37. Ruoff KL, Kuritzkes DR, Wolfson JS, et al. Vancomycin-resistant gram-positive bacteria isolated form human sources. J Clin Microbiol 1988;26:2064-8.
38. Handwerger S, Horowitz H, Coburn K, et al. Infection due to Leuconostoc species: six cases and review. Rev Infect Dis 1990;12 602-10.
39. Espinoza-Araya R. Leuconostoc species. In: Yu VL, Merigan TC Jr, Barriere SL, editors. Antimicrobial therapy and vaccines. Baltimore: Williams & Wilkins; 1999. p. 275-7.
40. Golledge CL. Bacteremia due to Leuconostoc species. Clin Microbiol Newsl 1989;11:29-30.
41. Giraud P, Attal M, Lemouzy J, et al. Leuconostoc, a potential pathogen in bone marrow transplantation [letter]. Lancet 1993;341:1481-2.
42. Mastro TD, Spika JS, Lozano P, et al. Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis 1990;161:956-60.
43. Golledge CL, Stingemore N, Aravena M, et al. Septicemia caused by vancomycin-resistant Pediococcus acidilactici. J Clin Microbiol 1990;28:1678-9.
44. Tankovic J, Leclercq R, Duval J. Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020. Antimicrob Agents Chemother 1993;37:789-92.